Real-life Experience of Brentuximab Vedotin Plus CHP as First-line Treatment of CD30+ Peripheral T-cell Lymphomas in Spain
Clinical trial NCT07624838 · RECRUITING
Trial details
- NCT number
- NCT07624838
- Sponsor
- Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2026-02-15
- Primary completion
- 2026-11-01
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.